Filtering by:
Cancer UpdatesCancer Patients Want More Information From Doctors About Cost
A study led by researchers from University of Michigan has found that many cancer patients would like more help from their health care providers in addressing costs of treatment.
FDA Approves Poteligeo (Mogamulizumab) for Lymphoma of the Skin
The US Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab) to treat people with some types of skin lymphoma.
FDA Approves Azedra (Iobenguane) for Rare Adrenal Tumors
The US Food and Drug Administration has approved the radiotherapy drug Azedra (iobenguane I-131) to treat some adults and adolescents ages 12 and older with rare tumors of the adrenal gland called pheochromocytomas, as well as for similar tumors outside of the adrenals, called paragangliomas.
‘Incidental’ Imaging Findings Unlikely to be Cancer
Researchers from University of Oxford and Stanford University have reviewed hundreds of studies to learn how often incidental abnormal findings from imaging tests are found, how often those turn out to be malignant tumors, and how often they turn out to be harmless.
FDA Approves Tibsovo (Ivosidenib) for Acute Myeloid Leukemia (AML)
The US Food and Drug Administration (FDA) has approved the targeted therapy drug Tibsovo (ivosidenib) to treat some adults with a certain type of acute myeloid leukemia (AML).
Study: Outcomes Similar for Robotic vs. Traditional Bladder Cancer Surgery
Surgeons at 15 medical centers in the US have compared the outcomes of robotic surgery to traditional open surgery for bladder cancer. The study found outcomes to be similar for both types of surgery.
Studies Compare Flap With Implant Breast Reconstruction After Mastectomy
Breast cancer surgeons from the University of Michigan and colleagues have compared different methods of breast reconstruction used after mastectomy in 2 different studies. The studies looked at procedures that use implants and “flap” procedures.
Sitting Time Linked to Higher Risk of Death from All Causes
A study from the American Cancer Society finds a link between long periods of leisure time sitting and a higher risk of death from all causes, including 14 of the 22 causes of death measured by the study.